ORAP 2 mg Oral Tablet
RxNorm 201653
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 201653 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ORAP 2 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSN
Prescribable Name (PSN):
ORAP 2 mg Oral Tablet
(Atom ID: 6361207)
SY
Synonym (SY):
Orap 2 mg Oral Tablet
(Atom ID: 1134229)
SBD
Semantic Branded Drug (SBD):
Pimozide 2 mg Oral Tablet [Orap]
(Atom ID: 12355217)
Patient Education
Pimozide
Pimozide is used to control motor or verbal tics (an uncontrollable need to repeat certain movements or sounds) caused by Tourette's disorder (condition characterized by motor or verbal tics). Pimozide should only be used to treat people who cannot take other medications or who have taken other medications without good results. Pimozide should only be used to treat severe tics that stop the person from learning, working, or performing daily activities. Pimozide is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.